Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
US FDA’s Failure To Implement Key Workforce Reforms Puts Oversight At Risk, GAO Says
Feb 03 2026
•
By
Sue Sutter
The FDA failed to implement numerous recommendations aimed at improving regulatory oversight.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from United States